Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 175

1.

A single heteroclitic epitope determines cancer immunity after xenogeneic DNA immunization against a tumor differentiation antigen.

Gold JS, Ferrone CR, Guevara-Patiño JA, Hawkins WG, Dyall R, Engelhorn ME, Wolchok JD, Lewis JJ, Houghton AN.

J Immunol. 2003 May 15;170(10):5188-94.

PMID:
12734366
[PubMed - indexed for MEDLINE]
Free Article
2.

CTL-dependent and -independent antitumor immunity is determined by the tumor not the vaccine.

Leitch J, Fraser K, Lane C, Putzu K, Adema GJ, Zhang QJ, Jefferies WA, Bramson JL, Wan Y.

J Immunol. 2004 May 1;172(9):5200-5.

PMID:
15100257
[PubMed - indexed for MEDLINE]
Free Article
3.

Synergistic effect of a combined DNA and peptide vaccine against gp100 in a malignant melanoma mouse model.

Nawrath M, Pavlovic J, Moelling K.

J Mol Med (Berl). 2001 Apr;79(2-3):133-42.

PMID:
11357937
[PubMed - indexed for MEDLINE]
4.

Hydrodynamic limb vein delivery of a xenogeneic DNA cancer vaccine effectively induces antitumor immunity.

Neal ZC, Bates MK, Albertini MR, Herweijer H.

Mol Ther. 2007 Feb;15(2):422-30.

PMID:
17235322
[PubMed - indexed for MEDLINE]
5.

Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100.

Zhai Y, Yang JC, Spiess P, Nishimura MI, Overwijk WW, Roberts B, Restifo NP, Rosenberg SA.

J Immunother. 1997 Jan;20(1):15-25.

PMID:
9101410
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity.

Hawkins WG, Gold JS, Dyall R, Wolchok JD, Hoos A, Bowne WB, Srinivasan R, Houghton AN, Lewis JJ.

Surgery. 2000 Aug;128(2):273-80.

PMID:
10923004
[PubMed - indexed for MEDLINE]
7.

Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.

Yang S, Vervaert CE, Burch J Jr, Grichnik J, Seigler HF, Darrow TL.

Int J Cancer. 1999 Nov 12;83(4):532-40.

PMID:
10508491
[PubMed - indexed for MEDLINE]
8.

Transgenic expression of human gp100 and RANTES at specific time points for suppression of melanoma.

Aravindaram K, Yu HH, Lan CW, Wang PH, Chen YH, Chen HM, Yagita H, Yang NS.

Gene Ther. 2009 Nov;16(11):1329-39. doi: 10.1038/gt.2009.90. Epub 2009 Jul 23.

PMID:
19626052
[PubMed - indexed for MEDLINE]
9.

Protective immunization against melanoma by gp100 DNA-HVJ-liposome vaccine.

Zhou WZ, Kaneda Y, Huang S, Morishita R, Hoon D.

Gene Ther. 1999 Oct;6(10):1768-73.

PMID:
10516727
[PubMed - indexed for MEDLINE]
Free Article
10.

DNA fusion vaccine designed to induce cytotoxic T cell responses against defined peptide motifs: implications for cancer vaccines.

Rice J, Elliott T, Buchan S, Stevenson FK.

J Immunol. 2001 Aug 1;167(3):1558-65.

PMID:
11466377
[PubMed - indexed for MEDLINE]
Free Article
11.

Oral DNA vaccination: antigen uptake and presentation by dendritic cells elicits protective immunity.

Cochlovius B, Stassar MJ, Schreurs MW, Benner A, Adema GJ.

Immunol Lett. 2002 Feb 1;80(2):89-96.

PMID:
11750039
[PubMed - indexed for MEDLINE]
12.

Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy.

Zhai Y, Yang JC, Kawakami Y, Spiess P, Wadsworth SC, Cardoza LM, Couture LA, Smith AE, Rosenberg SA.

J Immunol. 1996 Jan 15;156(2):700-10.

PMID:
8543823
[PubMed - indexed for MEDLINE]
13.

Analysis of antitumor activity elicited by vaccination with combinations of interleukin-12 DNA with gp100 DNA or the chemokine CCL21 in vivo.

Elzaouk L, Pavlovic J, Moelling K.

Hum Gene Ther. 2006 Aug;17(8):859-70.

PMID:
16942445
[PubMed - indexed for MEDLINE]
14.

Adoptive T cell immunotherapy of human uveal melanoma targeting gp100.

Sutmuller RP, Schurmans LR, van Duivenvoorde LM, Tine JA, van Der Voort EI, Toes RE, Melief CJ, Jager MJ, Offringa R.

J Immunol. 2000 Dec 15;165(12):7308-15.

PMID:
11120866
[PubMed - indexed for MEDLINE]
Free Article
15.

Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma.

Niethammer AG, Xiang R, Ruehlmann JM, Lode HN, Dolman CS, Gillies SD, Reisfeld RA.

Cancer Res. 2001 Aug 15;61(16):6178-84.

PMID:
11507070
[PubMed - indexed for MEDLINE]
Free Article
16.

Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.

Kaplan JM, Yu Q, Piraino ST, Pennington SE, Shankara S, Woodworth LA, Roberts BL.

J Immunol. 1999 Jul 15;163(2):699-707.

PMID:
10395660
[PubMed - indexed for MEDLINE]
Free Article
17.

Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice.

Touloukian CE, Leitner WW, Topalian SL, Li YF, Robbins PF, Rosenberg SA, Restifo NP.

J Immunol. 2000 Apr 1;164(7):3535-42.

PMID:
10725708
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Genetic immunization of mice with human tyrosinase-related protein 2: implications for the immunotherapy of melanoma.

Steitz J, Brück J, Steinbrink K, Enk A, Knop J, Tüting T.

Int J Cancer. 2000 Apr 1;86(1):89-94.

PMID:
10728600
[PubMed - indexed for MEDLINE]
19.

Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma.

Bellone M, Cantarella D, Castiglioni P, Crosti MC, Ronchetti A, Moro M, Garancini MP, Casorati G, Dellabona P.

J Immunol. 2000 Sep 1;165(5):2651-6.

PMID:
10946294
[PubMed - indexed for MEDLINE]
Free Article
20.

In vivo plasmid electroporation induces tumor antigen-specific CD8+ T-cell responses and delays tumor growth in a syngeneic mouse melanoma model.

Kalat M, Küpcü Z, Schüller S, Zalusky D, Zehetner M, Paster W, Schweighoffer T.

Cancer Res. 2002 Oct 1;62(19):5489-94.

PMID:
12359758
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk